Clinical trial
Efficacy of Desvenlafaxine in the Preventive Treatment of Frequent Migraines -- Multicenter, Prospective, Randomized, Controlled Study
NCT07385755 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Desvenlafaxine in the Preventive Treatment of Frequent Migraines -- Multicenter, Prospective, Randomized, Controlled Study
- Lead sponsor
- Tongji Hospital
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 1, 2026
- Completion date
- January 1, 2028
- Enrollment
- 440 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
migraine